eli lilly zepbound tirzepatide FDA approval for (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly weight-loss drug appears

The combination produced greater weight loss, blunted the weight regain that often follows treatment, sustained glucose control and, notably, helped prevent the muscle (grip-strength) loss seen with the drug alone

If your digestive systemwhich is designed to absorb nutrientscant fully take in GLP-1 medications, your skin poses an even bigger challenge

The combination of these two dehydrating factors can lead to electrolyte imbalances, headaches, dizziness, and fatigue (5)

Looking ahead: Toward a brighter future Though the idea of a cure remains a long-term goal, recent scientific findings build hope for more effective interventions, earlier diagnosis, and potentially reversible conditions

However, there are certain adverse reactions